FDA Approves Oral Form of ALS Drug Edaravone FDA Approves Oral Form of ALS Drug Edaravone

The FDA has approved an orally administered version of edaravone for adults with amyotrophic lateral sclerosis.FDA Approvals

Source: Medscape Neurology and Neurosurgery Headlines - May 13, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news